A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds
|
|||||
|
|
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug  Comments are closed  New products  biomedical, biotechnology, clinical trials, Europe, licensing, life sciences, pharmaceuticals, psychiatric, U.K. A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, licensing, life sciences, merger, NIH, pharmaceuticals Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals, U.K. In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes Comments are closed New products biomedical, clinical trials, Europe, licensing, life sciences, pharmaceuticals, U.K., university A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students. . . . → Read More: University Spins Off Educational Robot Start-Up Comments are closed Finance, New products computer science, crowdfunding, engineering, entrepreneurs, equity, investment, licensing, mathematics, physical sciences, robotics, software, university, venture capital A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app. . . . → Read More: Trial to Test Inhaled Insulin, App for Diabetes Mgmt Comments are closed Joint ventures/collaborations, Regulations biomedical, clinical trials, engineering, licensing, life sciences, medical device, pharmaceuticals Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo. . . . → Read More: Migraine Treatment Shown Effective in Late Trial Comments are closed New products, Regulations biomedical, clinical trials, licensing, life sciences, pharmaceuticals |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
